Therefore, based on the role of PFKFB3 in angiogenesis and AAT resistance, we hypothesized that dual inhibition of PFKFB3 and VEGF could reinforce the TVN effect in GBM, thereby remodeling tumor microenvironment to create a more sustained window of opportunity to improve chemotherapy outcome. This evidence concerns the gene PFKFB3 and neoplasm.